Concepedia

Juan Pablo Alderuccio

JP

38

Publications

1.4K

Citations

19

H-Index

2013

Active since

Affiliations

Sylvester Comprehensive Cancer Center(Current)

University of Miami

The University of Texas MD Anderson Cancer Center

Washington University in St. Louis

Cornell University

Juan Pablo Alderuccio is an author at Sylvester Comprehensive Cancer Center specializing in medicine, pathology, and immunology.

ORCID

Top concepts

Publications per year

2013–2024

38

Publications

38

Loncastuximab tesirine in relapsed or refractory diffuse large B-cell lymphoma (LOTIS-2): a multicentre, open-label, single-arm, phase 2 trial

Paolo F. Caimi, Weiyun Z. Ai, Juan Pablo Alderuccio et al. · The Lancet Oncology · 2021 · 397 citations

, , +6

Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers

Andrew M. Evens, Alexey V. Danilov, Deepa Jagadeesh et al. · Blood · 2021 · 122 citations · Full text

Risk Factors for Transformation to Higher-Grade Lymphoma and Its Impact on Survival in a Large Cohort of Patients With Marginal Zone Lymphoma From a Single Institution

Juan Pablo Alderuccio, Wei Zhao, Amrita Desai et al. · Journal of Clinical Oncology · 2018 · 75 citations

Bilateral radiation therapy followed by methotrexate‐based chemotherapy for primary vitreoretinal lymphoma

Macarena I. de la Fuente, Juan Pablo Alderuccio, Isildinha M. Reis et al. · American Journal of Hematology · 2019 · 59 citations · Full text

, , +16

HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysis

Juan Pablo Alderuccio, Adam J. Olszewski, Andrew M. Evens et al. · Blood Advances · 2021 · 51 citations · Full text

Rows per page

1–5 of 38